Company Details

Lee's Pharmaceutical (HK) Limited

Lee's Pharm (HKEx: 0950) is a research-based biopharmaceutical company listed in Hong Kong with over 20 years operation in China's pharmaceutical industry. It is fully integrated with strong infrastructures in drug development, manufacturing, sales and marketing. It has established extensive partnership with over 20 international companies and currently has 14 products in the market place. Lee's Pharm focuses on several key disease areas such as cardiovascular diseases, oncology, gynecology, dermatology and ophthalmology. Lee's Pharm development program is lauded with 30 products stemming from both internal R&D efforts and collaborations with US, European and Japanese companies and aspires to combat diseases such as liver cancer and pulmonary hypertension. In 2010, Lee’s has been honored an outstanding achievement in ranking “No. 2 of (China) Best Small-Cap” in the Asia’s Best Companies Poll conducted by the leading regional financial magazine FinanceAsia showing the extensive recognition in the investment community of its seasoned management and effective corporate governance. Since 2011, Lee’s was awarded as one of the “Best Under a Billion” companies by Forbes Asia for consecutive three years. The election of the final 200 with entrepreneurial characteristics is based on earning growth, sales growth and shareholders’ return on equity in the past 12 months and over three years. The mission of Lee’s is to become a successful biopharmaceutical group in Asia providing innovative products to fight diseases and improve health and quality of life. Additional information about Lee's Pharmaceutical is available at

The information provided on this page is for reference only. Please refer to the latest information published by the partner company.

Contact Us

For general enquiry, or questions about HKSTP’s services and support, please enter your email address and query here.